Lv11
28 积分 2024-11-03 加入
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study
7分钟前
已完结
3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial
9分钟前
已完结
Enhancing the Safety and Efficacy of Trastuzumab Emtansine (T‐DM1) Through Nano‐Delivery System in Breast Cancer Therapy
1天前
已完结
Peptide-drug conjugates: A new paradigm for targeted cancer therapy
8天前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
8天前
已完结
Discovery of Ketal‐Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery
1个月前
已完结
Immunotherapy against colorectal cancer via delivery of anti-PD-L1 nanobody mRNA
1个月前
已关闭
Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis
1个月前
已完结
Carrier-Free Nanoprodrug Mediating Laser-Activable Chemotherapeutic Immunomodulation against Cancer
1个月前
已完结
Engineering multi-specific nano-antibodies for cancer immunotherapy
2个月前
已完结
皖公网安备34019202002308
